Laboratory of Animal Disease Prevention and Control and Animal Model, Hunan Provincial Key Laboratory of Protein Engineering in Animal Vaccines, College of Veterinary Medicine, Hunan Agricultural University (HUNAU), Changsha, 410128, China.
Yunnan Tropical and Subtropical Animal Virus Diseases Laboratory, Yunnan Animal Science and Veterinary Institute, Kunming, 650224, China.
Virol Sin. 2021 Aug;36(4):588-607. doi: 10.1007/s12250-020-00340-0. Epub 2021 Feb 22.
Pseudorabies (PR), also called Aujeszky's disease, is a highly infectious disease caused by pseudorabies virus (PRV). Without specific host tropism, PRV can infect a wide variety of mammals, including pig, sheep, cattle, etc., thereby causing severe clinical symptoms and acute death. PRV was firstly reported in China in 1950s, while outbreaks of emerging PRV variants have been documented in partial regions since 2011, leading to significant economic losses in swine industry. Although scientists have been devoting to the design of diagnostic approaches and the development of vaccines during the past years, PR remains a vital infectious disease widely prevalent in Chinese pig industry. Especially, its potential threat to human health has also attracted the worldwide attention. In this review, we will provide a summary of current understanding of PRV in China, mainly focusing on PRV history, the existing diagnosis methods, PRV prevalence in pig population and other susceptible mammals, molecular characteristics, and the available vaccines against its infection. Additionally, promising agents including traditional Chinese herbal medicines and novel inhibitors that may be employed to treat this viral infection, are also discussed.
伪狂犬病(PR),又称阿育泽病,是由伪狂犬病病毒(PRV)引起的一种高度传染性疾病。PRV 没有特定的宿主趋向性,可以感染包括猪、羊、牛等在内的多种哺乳动物,从而导致严重的临床症状和急性死亡。PRV 于 20 世纪 50 年代在中国首次报道,自 2011 年以来,部分地区已记录到新兴 PRV 变异株的爆发,给养猪业造成了重大经济损失。尽管科学家们在过去的几年中一直致力于诊断方法的设计和疫苗的开发,但 PR 仍然是中国养猪业广泛流行的重要传染病。特别是其对人类健康的潜在威胁也引起了全世界的关注。在这篇综述中,我们将对中国的 PRV 进行概述,主要集中在 PRV 的历史、现有的诊断方法、猪群和其他易感哺乳动物中的 PRV 流行情况、分子特征以及针对其感染的现有疫苗。此外,还讨论了可能用于治疗这种病毒感染的有前途的药物,包括中药和新型抑制剂。